Santen Pharmaceutical Co., Ltd. held its 107th Annual General Meeting of Shareholders for the fiscal year 2018 on June 25, 2019. The Meeting started at 10:00 a.m. and ended at 11:38 a.m. The number of shareholders attended was 209.
| Matters reported | - Business Report, Consolidated Financial Statements and Non-consolidated Financial Statements for the 107th Business Term (April 1, 2018 to March 31, 2019)
- Independent Auditors Report and Corporate Auditors Report on the consolidated Financial Statements for the 107th Business Term (April 1, 2018 to March 31, 2019)
|
|---|
| Questions | We received questions regarding the following subjects from 9 shareholders and responded in kind.- Regarding standard of trade receivables
- Regarding global cash management.
- Regarding current share price
- Regarding trend of OTC sales.
- Regarding business expansion other than ophthalmic drugs.
- Regarding abolition of hand gifts to attended shareholders.
- Regarding questionnaire to shareholders.
- Regarding attendance card.
- Regarding disaster-prevention for earthquake and etc. in domestic manufacturing plant.
- Regarding bottle design of Soft Santear ®
- Regarding sales promotion enhancement through internet
- Regarding employment's willingness to work
- Regarding plan for headquarter relocation to Tokyo.
- Regarding reason for the long-term loans payable increase.
|
|---|
| Matters resolved | Three proposals were all resolved.
Please refer to the Resolution Notice (PDF: 230KB)PDF file.Page will open in a new window. for detailed resolutions. |
|---|
